Logo
 Home | Sitemap | Contact us | Search | Language
Left Right
Home >> Biotechnology and Genomics >> Triplex DNA, TFOs, PNAs, RNA-DNA Hybrids and dsRNA - RNAi >> Gene Alterations Using TFOs

Gene alteration using TFOs
Triple helix forming oligonucleotides (TFOs) recognize and bind sequence in duplex DNA and have received attention due to their potential for targeting specific genomic sites. Three different mechanisms of triplex mediated interference with DNA information processing are shown in. DNA cross-linking reagent psoralen has been used for linking to prepare modified TEOs, that may be directed to a specific site of a gene. For instance, in Chinese Hamster hypoxanthine phosphoribosyl transferase (Hprt) gene, in exon E4 and immediately adjacent to the smallest exon E5, there is a polypyrimidine:

Polypurine sequence. The sequence has a run of 23 pyrimidines interrupted by a single purine (AT inversion). At the proximal end of exon E5, there is a 5 TA, which can be cross-linked by psoralen. While all mutations at T (T→ C and T→A) are silent, those at A residue would inactivate the AG splice acceptor sequence. The above 23 pyrimidines long sequence had a purine interruption due to At inversion. Such inversions in an otherwise perfect purine : pyrimidine run destabilizes a triplex containing a third strand with a pyrimidine run.

Gene Alterations using TFOS

Different Mechanisms of TFO mediated Alterations in DNA.

Different Mechanisms of TFO mediated Alterations in DNA.

Different Mechanisms of TFO mediated Alterations in DNA.

Different Mechanisms of TFO mediated Alterations in DNA.

Different Mechanisms of TFO mediated alterations in DNA.



It has been shown that replacement of a base in a TFO with an intercalator (e.g. pyrene or acridine) at Ta inversion site stabilizes triplexes. When TFOs carrying intercalators at the inversion site were used with cells that were electroporated and UV-A treated, large number (77% clones) of deletions (4-50 bases long) and point mutations (4%) were deteched. Point mutations were located mainly at the cross-linking site.

The TEOs thus are capable of delivering psoralen at the target sequence and enhance the frequency of mutagenesis few hundred fold relative to spontaneous mutations. No increase in mutation frequency was observed, when either TFOs without psoralen were introduced in the cell or when psoralen-
TFO were not protected against nucleases.

 

Left Right